<DOC>
	<DOCNO>NCT01774396</DOCNO>
	<brief_summary>Assessment efficacy hyaluronic acid - Emervel速 Volume Lidocaine combine Emervel速 Touch Emervel速 Deep Lidocaine combine Emervel速 Touch female patient loss fatty tissue hand .</brief_summary>
	<brief_title>Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid In Hands Rejuvenation</brief_title>
	<detailed_description>This single center , phase IV , randomize , investigator-blind study three different hyaluronic dermal filler injection volume enhance dorsum hand . As investigator-blind study , investigator unaware dermal filler inject dorsum hand .</detailed_description>
	<mesh_term>Finger Injuries</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Subjects agree take part procedure study ( include pretest , filler injection , photograph , etc . ) , fully inform objective nature investigation ; Written Informed Consent ; Treatmentnaive patient filler hand ; Subjects gender 18 year ; Fitzpatrick skin phototypes I VI ; Subjects present similar loss fatty tissue hand , least 2 accord Validated Hand Grading Scale2 ; Medical history physical examination , base investigator 's opinion , prevent patient take part study use product investigation ; Female subject childbearing age present negative urine pregnancy test use effective contraceptive method ; Availability subject throughout duration study ( 208 day ) ; Subjects sufficient school awareness enable cooperate degree require protocol . Pregnant woman woman intend become pregnant next 18 month ; Subjects know hypersensitivity hyaluronic acid product ; Subjects history adverse effect , sensitivity component formula , adverse effect , investigator 's opinion prevent patient participate study ; Subjects participate clinical trial ; Any prior surgery side effect hand area , prior cosmetic procedure , include permanent filler , may interfere result ; Subjects active inflammation infection area treat ; Subjects history medical treatment nonadherence show unwillingness adhere study protocol ; Subjects present disease coagulation disorder use anticoagulant , condition , opinion investigator , compromise evaluation study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Hands Rejuvenation , filler</keyword>
</DOC>